Isoform selective PI3 kinase inhibitors for cancer, thrombosis and inflammatory disease

Thompson, Phillip, (Primary Chief Investigator (PCI))

Medicine Nursing and Health Sciences Faculty Office

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/16

Funding

National Health & Medical Research Council (NHMRC): AUD462,809.20

Related content

Research Output

Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ

Research output: Contribution to journal › Article › Research › peer-review

Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)

Research output: Contribution to journal › Article › Research › peer-review